Evidence map›Paper›PMID 27824866›Full record

ArticlePloS one2016

A Field-Tailored Reverse Transcription Loop-Mediated Isothermal Assay for High Sensitivity Detection of Plasmodium falciparum Infections.

Sylvie Kemleu, Dylan Guelig, Carole Eboumbou Moukoko, Estelle Essangui, Steven Diesburg, Abas Mouliom, Bernard Melingui, Jeanne Manga, Christiane Donkeu, Annie Epote and 4 more

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Direct Detection of SARS-CoV-2 RNA in Saliva with Colorimetric RT-LAMP.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sylvie KemleuMalaria Research Unit, Centre Pasteur du Cameroun, Yaoundé, Cameroon.
Dylan GueligPATH, Seattle, Washington, United States of America.
Carole Eboumbou MoukokoMalaria Research Unit, Centre Pasteur du Cameroun, Yaoundé, Cameroon.
Estelle EssanguiMalaria Research Unit, Centre Pasteur du Cameroun, Yaoundé, Cameroon.
Steven DiesburgPATH, Seattle, Washington, United States of America.
Abas MouliomHematology Unit, Centre Pasteur du Cameroun, Yaoundé, Cameroon.
Bernard MelinguiHematology Unit, Centre Pasteur du Cameroun, Yaoundé, Cameroon.
Jeanne MangaHematology Unit, Centre Pasteur du Cameroun, Yaoundé, Cameroon.
Christiane DonkeuMalaria Research Unit, Centre Pasteur du Cameroun, Yaoundé, Cameroon.
Annie EpoteHematology Unit, Centre Pasteur du Cameroun, Yaoundé, Cameroon.
Gaëtan TexierPublic Health & Epidemiology Unit, Centre Pasteur du Cameroun, Yaoundé, Cameroon.
Paul LaBarrePATH, Seattle, Washington, United States of America.
Robert BurtonPATH, Seattle, Washington, United States of America.
Lawrence AyongMalaria Research Unit, Centre Pasteur du Cameroun, Yaoundé, Cameroon.ORCID http://orcid.org/0000-0001-7717-4832

Funding

CaO-heated DNA amplification obviates electricity requirement at point of careR01EB012641 · NIBIB · PATH · PI BURTON, ROBERT ANDREW · 2011 to 2013
$1.8M
NIBIB NIH HHS R01 EB012641
6 · The paper itself

Abstract

Highly sensitive and field deployable molecular diagnostic tools are critically needed for detecting submicroscopic, yet transmissible levels of malaria parasites prevalent in malaria endemic countries worldwide. A reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay was developed and evaluated in comparison with thick blood smear microscopy, an antigen-based rapid diagnostic test (RDT), and an in-house RT-PCR targeting the same RT-LAMP transcript. The optimized assay detected Plasmodium falciparum infections in as little as 0.25ng of total parasite RNA, and exhibited a detection limit of 0.08 parasites/ μL when tested directly on infected whole blood lysates, or ~0.0008 parasites/ μL when using RNA extracts. Assay positivity was observed as early as eight minutes from initiation of the RT-LAMP and in most cases the reaction was complete before twenty minutes. Clinical evaluation of the assay on 132 suspected malaria cases resulted in a positivity rate of 90% for RT-LAMP using extracted RNA, and 85% when using whole blood lysates. The positivity rates were 70% for P. falciparum-specific RDT, 83% for RT-PCR, and 74% for thick blood smear microscopy (Mean parasite density = 36,986 parasites/ μL). Concordance rates between the developed RT-LAMP and comparator tests were greater than 75%, the lowest being with light microscopy (78%, McNemar's test: P = 0.0002), and the highest was with RT-PCR (87%, McNemar's test: P = 0.0523). Compared to reference RT-PCR, assay sensitivity was 90% for RT-LAMP on whole blood, and 96% for RT-LAMP using corresponding RNA extracts. Electricity-free heaters were further developed and evaluated in comparison with a battery-operated isothermal amplification machine for use with the developed test in resource-limited settings. Taken together, the data highlight the benefits of targeting high abundant RNA transcripts in molecular diagnosis, as well as the potential usefulness of the developed RT-LAMP-assay in malaria diagnosis in low to high parasite density settings.

Indexed as

Base SequenceHumansLimit of DetectionMalaria, FalciparumMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesPlasmodium falciparumReverse TranscriptionSensitivity and SpecificitySequence Alignment

Identifiers

PMID27824866
PMCPMC5100904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.